Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2022

Genmab — Oktober 2022

Planlagt Fastgjort Låst Flyttet Genmab
641 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #505

    Nice and exciting - something new to dig into

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #506

      yes, because of the old one is why i doubted, but it seems legit https://www.voxmarkets.co.uk/rns/announcement/ce23680d-baba-4c59-8799-148dc5f9cfe0/

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #507

        Få overblik over de mange kommende regnskaber med Proinvestors Finanskalender. https://www.proinvestor.com/finanskalender

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #508

          Genmab-middel tæt på blockbustersstatus – Novartis øger salget 172 pct https://medwatch.dk/Medicinal___Biotek/article14522664.ece

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bikube
            wrote on sidst redigeret af
            #509

            Hvad er royalti% til Genmab på Kesimpta?

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #510

              10 %

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #511

                Tak.

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #512

                  https://endpts.com/fda-approves-jjs-bcma-targeted-bispecific-for-multiple-myeloma/

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #513

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #514

                      Godmorgen 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #515

                        USA/lukning: Rentefald sendte aktier op - Tesla, Apple i front

                        Just a moment...

                        favicon

                        (www.proinvestor.com)

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Stroka
                          wrote on sidst redigeret af
                          #516

                          God morgen. 🙂

                          1 Reply Last reply
                          0
                          • DarvinD Offline
                            DarvinD Offline
                            Darvin
                            wrote on sidst redigeret af
                            #517

                            Site Maintenance

                            favicon

                            (www.jnj.com)

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #518

                              U.S. Food and Drug Administration (FDA) approved TECVAYLI™ (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #519

                                Genmab: Janssen får godkendt middel
                                baseret på duobody https://www.proinvestor.com/investornyt/895264/genmab-janssen-far-godkendt-middel-baseret-pa-duobody-gent

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  GeorgeBest
                                  wrote on sidst redigeret af
                                  #520

                                  Kate Sasser (som ofte er blevet fremhævet af JvdW), forlader Genmab og har fået job hos Tempus. Tempus er en af Genmabs partnere. Kilde LinkedIn.

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #521

                                    Artiklen fra FDA. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-teclistamab-cqyv-relapsed-or-refractory-multiple-myeloma

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #522

                                      'Bernadette King, a J&J spokesperson, told Endpoints via email that in its clinical trial, the average patient was treated for 9 to 10 months. Based on this, the total cost of therapy ranges between a list price of $355,000 and $395,000 – or $39,500 per month.'........ https://endpts.com/fda-approves-jjs-bcma-targeted-bispecific-for-multiple-myeloma/

                                      1 Reply Last reply
                                      0
                                      • SvingtraderenS Offline
                                        SvingtraderenS Offline
                                        Svingtraderen
                                        wrote on sidst redigeret af
                                        #523

                                        Med partneren Janssens godkendelse tirsdag af kræftmidlet Tecvayli i USA, har Genmab fået en ekstra kilde til indtjening, der vil medvirke til, at selskabet bliver endnu mindre afhængig af sin supersællert Darzalex.

                                        Det konstaterer analytiker i Sydbank Søren Løntoft Hansen, efter at den amerikanske lægemiddelstyrelse tirsdag godkendte Tecvayli til uhelbredeligt syge patienter med knoglemarvskræft, der i forvejen har modtaget mindst fire andre behandlinger.

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #524

                                          Just a moment...

                                          favicon

                                          (www.proinvestor.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper